Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Diabetes Care 29:283-289, 2006
DOI: 10.2337/diacare.29.02.06.dc05-1715
© 2006 by the American Diabetes Association
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sampson, M. J.
Right arrow Articles by Hughes, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sampson, M. J.
Right arrow Articles by Hughes, D. A.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pathophysiology/Complications
Original Article

Monocyte Telomere Shortening and Oxidative DNA Damage in Type 2 Diabetes

Mike J. Sampson, MD1, Mark S. Winterbone, BSC2, Jackie C. Hughes, BSC2, Nicoletta Dozio, PHD1 and David A. Hughes, PHD2

1 Bertram Diabetes Research Unit, Norfolk and Norwich University Hospital National Health Service Trust, Norwich, U.K.
2 Institute of Food Research, Norwich Research Park, Norwich, U.K.

Address correspondence and reprint requests to Dr. Mike Sampson, Elsie Bertram Diabetes Centre, NorfolkNorwich University Hospital National Health Service Trust, Norwich NR4 7UA, U.K. E-mail: mike.sampson{at}nnuh.nhs.uk

OBJECTIVE—Telomeres are DNA sequences necessary for DNA replication, which shorten at cell division at a rate related to levels of oxidative stress. Once shortened to a critical length, cells are triggered into replicative senescence. Type 2 diabetes is associated with oxidative DNA damage, and we hypothesized that telomere shortening would characterize type 2 diabetes.

RESEARCH DESIGN AND METHODS—We studied 21 male type 2 diabetic subjects (mean age 61.2 years, mean HbA1c 7.9%) selected to limit confounding effects on telomere length and 29 matched control subjects. Telomere length was measured in peripheral venous monocyte and T-cells (naïve and memory) by fluorescent in situ hybridization and oxidative DNA damage by flow cytometry of oxidized DNA bases. Peripheral insulin resistance (homeostasis model assessment) and high-sensitivity C-reactive protein (hsCRP) were measured.

RESULTS—Mean monocyte telomere length in the diabetic group was highly significantly lower than in control subjects (4.0 [1.1] vs. 5.5 [1.1]; P < 0.0001), without significant differences in lymphocyte telomere length. There was a trend toward increased oxidative DNA damage in all diabetes cell types examined and a significant inverse relationship between oxidative DNA damage and telomere length (r = –0.55; P = 0.018) in the diabetic group. Telomere length was unrelated to plasma CRP concentration or insulin resistance.

CONCLUSIONS—Monocyte telomere shortening in type 2 diabetes could be due to increased oxidative DNA damage to monocyte precursors during cell division. This data suggests that monocytes adhering to vascular endothelium and entering the vessel wall in type 2 diabetes are from a population with shorter telomeres and at increased risk of replicative senescence within vascular plaque.

Abbreviations: FITC, fluorescein isothiocyanate • HOMA, homeostasis model assessment • hsCRP, high- sensitivity C-reactive protein • MESF, mean monocyte telomere length • PBMC, peripheral blood mononuclear cell


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Gerontol. A Biol. Sci. Med. Sci.Home page
J. Z. Guan, T. Maeda, M. Sugano, J.-i. Oyama, Y. Higuchi, T. Suzuki, and N. Makino
A Percentage Analysis of the Telomere Length in Parkinson's Disease Patients
J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2008; 63(5): 467 - 473.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
N. J Samani and P. van der Harst
Biological ageing and cardiovascular disease
Heart, May 1, 2008; 94(5): 537 - 539.
[Full Text] [PDF]

Home page
 Arch Intern MedHome page
L. F. Cherkas, J. L. Hunkin, B. S. Kato, J. B. Richards, J. P. Gardner, G. L. Surdulescu, M. Kimura, X. Lu, T. D. Spector, and A. Aviv
The Association Between Physical Activity in Leisure Time and Leukocyte Telomere Length
Arch Intern Med, January 28, 2008; 168(2): 154 - 158.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Testa and A. Ceriello
Pathogenetic Loop Between Diabetes and Cell Senescence
Diabetes Care, November 1, 2007; 30(11): 2974 - 2975.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
N. Tentolouris, R. Nzietchueng, V. Cattan, G. Poitevin, P. Lacolley, A. Papazafiropoulou, D. Perrea, N. Katsilambros, and A. Benetos
White Blood Cells Telomere Length Is Shorter in Males With Type 2 Diabetes and Microalbuminuria
Diabetes Care, November 1, 2007; 30(11): 2909 - 2915.
[Abstract] [Full Text] [PDF]

Home page
 Am J EpidemiolHome page
A. L. Fitzpatrick, R. A. Kronmal, J. P. Gardner, B. M. Psaty, N. S. Jenny, R. P. Tracy, J. Walston, M. Kimura, and A. Aviv
Leukocyte Telomere Length and Cardiovascular Disease in the Cardiovascular Health Study
Am. J. Epidemiol., January 1, 2007; 165(1): 14 - 21.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
J. J. Fuster and V. Andres
Telomere Biology and Cardiovascular Disease
Circ. Res., November 24, 2006; 99(11): 1167 - 1180.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2006 by the American Diabetes Association.